US · Healthcare

Clinuvel Pharmaceuticals Ltd ADR (CLVLY)

Biotechnology

Clinuvel Pharmaceuticals Ltd ADR (CLVLY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CLVLY

P/E ratio

18.00

Clinuvel Pharmaceuticals Ltd ADR (CLVLY) — FAQ

What is CLVLY's P/E ratio?

The price-to-earnings (P/E) ratio for Clinuvel Pharmaceuticals Ltd ADR (CLVLY) is 18.00 (data as of 2026-03-23).

Does Clinuvel Pharmaceuticals Ltd ADR pay a dividend?

Dividend yield is not available in the current snapshot for Clinuvel Pharmaceuticals Ltd ADR (CLVLY). Check the MyAverix Finance app for the latest dividend data.

What sector is Clinuvel Pharmaceuticals Ltd ADR in?

Clinuvel Pharmaceuticals Ltd ADR (CLVLY) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CLVLY listed on?

CLVLY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)